Pallas Capital Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
+3,407
New +$223K 0.01% 680
2026
Q1
Sell
-3,433
Closed -$59.1K 864
2025
Q4
$59.1K Buy
+3,433
New +$66.6K ﹤0.01% 862
2025
Q2
Sell
-613
Closed -$66.3K 863
2025
Q1
$66.3K Buy
+613
New +$53.4K ﹤0.01% 721
2024
Q3
Sell
-441
Closed -$77.1K 599
2024
Q2
$77.1K Buy
+441
New +$62.8K ﹤0.01% 491

Other funds holding AGL

Pallas Capital Advisors's AGL Position: Q2 2026 in Review

Pallas Capital Advisors opened a new position in Agilon Health (AGL) in Q2 2026: 3,407 shares worth $365K. The stake represents 0.01% of the portfolio and ranks #680 among its holdings. This is a return to the name: Pallas Capital Advisors previously reported a position in AGL as recently as Q4 2025.

Pallas Capital Advisors first reported a position in AGL in Q2 2024 and has held it in 4 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Pallas Capital Advisors held 3,407 shares of Agilon Health worth $365K as of Q2 2026.
  • Agilon Health was a new Pallas Capital Advisors position in Q2 2026.
  • Agilon Health made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #680 holding.
  • Pallas Capital Advisors first reported a position in Agilon Health in Q2 2024 and has held it in 4 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.